U.S. flag

An official website of the United States government

New/Reinstated & Terminated Labeler Information

The information below identifies new/reinstated & terminated labelers. This page will be updated as new information is available so please check back often.

For definitions of optional and mandatory effective dates, please see the Medicaid National Drug Rebate Agreement (NDRA). Additionally, the Drug Manufacturer Contact Information contains Optional Effective Date, Termination Date (if applicable), and Legal, Invoice and Technical Contact information for each drug company participating in the MDRP. 

New/Reinstated Labelers

Labeler CodeLabeler NameOptional Effective Date (for State Coverage)Mandatory Effective Date (for State Coverage)
72964LIQUIDIA TECHNOLOGIES, INC.06/09/202510/01/2025
84386AUROBINDO PHARMA LTD05/12/202510/01/2025
85477ONCORA PHARMA04/30/202507/01/2025
83787LNHC, INC.04/29/202507/01/2025
82098RAYA PHARMACEUTICALS LLC04/18/202507/01/2025
83860SOLENO THERAPEUTICS, INC.04/17/202507/01/2025
73648MESOBLAST, INC.03/27/202507/01/2025
84054ALPHA COGNITION USA INC.03/24/202507/01/2025
71357MILLA PHARMACEUTICALS03/04/202507/01/2025
73159LACER PHARMA, LLC03/01/202507/01/2025
17270ARMSTRONG PHARMACEUTICALS, INC.02/21/202507/01/2025

Terminated Labelers

Labeler CodeLabeler NameEffective Date
80644ZEALAND PHARMA AS10/01/2025
64679WOCKHARDT USA, LLC07/01/2025
60432MORTON GROVE PHARMACEUTICALS, INC07/01/2025
60574MEDIMMUNE, INC.07/01/2025
72305PROVELL PHARMACEUTICALS, LLC07/01/2025
71308TREVENA, INC.07/01/2025
70003JACKSONVILLE PHARMACEUTICALS, INC.07/01/2025
70007ESPERO PHARMACEUTICALS, INC.07/01/2025
73380INNATE PHARMA, INC.07/01/2025
71351BROOKFIELD PHARMACEUTICALS, INC.07/01/2025
84275UNITY PHARMA07/01/2025

For questions, please contact MDRP Operations at MDROperations@cms.hhs.gov.

Disclaimer: Please note that the information provided on this web page does not bind or obligate the Centers for Medicare and Medicaid Services (CMS). The statements included on this web page are intended to provide information on New/Reinstated & Terminated Labelers and do not in any way revise or modify the requirements set forth in Section 1927 of the Act, the national drug rebate agreement (NDRA), subsequent program releases, or regulations.

Page last updated on June 9, 2025